Abbott Labs paying $9.5M in settlement over Depakote

Published



BATON ROUGE, La. (Legal Newsline) – Louisiana Attorney General Buddy Caldwell announced on Friday that his office obtained more than $9.5 million from Abbott Laboratories to resolve allegations of Medicaid fraud.

Caldwell’s office filed a lawsuit in 2011 against Abbott, alleging the company misbranded Depakote, an anti-epileptic medication. Abbott allegedly promoted the drug to control agitation and aggression in elderly dementia patients without approval from the U.S. Food and Drug Administration.

Trusted reporting.Unlimited access.

Subscribe for full access to Washington Examiner coverage, expert political analysis, and subscriber-only journalism.

Get Unlimited Access

Already a member? Log in

Cancel anytime.


Tag:

Law